Douglas O. Clary

5.4k citations

40 papers · 4.6k indexed · 2 hit papers · h-index 28

Molecular Biology top 2%
Cellular and Molecular Neuroscience top 2%
Genetics top 2%
Cell Biology top 1%
Insect Science top 1%

Co-authors: David R. Wolstenholme James E. Rothman Louis F. Reichardt Frances Lefcort John V. Priestley Stephen B. McMahon Melanie Brandabur Elliott J. Mufson
Topics: RNA and protein synthesis mechanisms (9 papers)Nerve injury and regeneration (8 papers)Mitochondrial Function and Pathology (6 papers)
Cited by: Developmental Neuroscience Cellular and Molecular Neuroscience Insect Science
Journals: Nature Cell Nucleic Acids Research
Partner nations: United States France Italy

In The Last Decade

Douglas O. Clary

40 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The mitochondrial DNA molecule ofDrosophila yakuba: Nucleotide sequence, gene organization, and genetic code

1985 1.4k citations Douglas O. Clary, David R. Wolstenholme Journal of Molecular Evolution profile →
SNAPs, a family of NSF attachment proteins involved in intracellular membrane fusion in animals and yeast

1990 447 citations Douglas O. Clary, James E. Rothman et al. Cell profile →

Peers

Countries citing papers authored by Douglas O. Clary

Since Specialization

Citations

This map shows the geographic impact of Douglas O. Clary's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas O. Clary with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas O. Clary more than expected).

Fields of papers citing papers by Douglas O. Clary

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas O. Clary. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas O. Clary. The network helps show where Douglas O. Clary may publish in the future.

Co-authorship network of co-authors of Douglas O. Clary

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas O. Clary. A scholar is included among the top collaborators of Douglas O. Clary based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas O. Clary. Douglas O. Clary is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical Outcomes by Nephrectomy Status In METEOR, A Randomized Phase 3 Trial of Cabozantinib Versus Everolimus in Patients with Advanced Renal Cell Carcinoma 2019 ·Työväentutkimus Vuosikirja ·Nizar M. Tannir,Thomas Powles,Bernard Escudier,Frede Donskov,Viktor Grünwald,Cora N. Sternberg,Manuela Schmidinger,Patrick Schöffski,Cezary Szczylik,(unknown),Dmitry Nosov,Bohuslav Melichar,Douglas O. Clary,Christian Scheffold,Robert J. Motzer,Toni K. Choueiri	1
2	Phase I study of XL281 (BMS-908662), a potent oral RAF kinase inhibitor, in patients with advanced solid tumors 2014 ·Investigational New Drugs ·Mark A. Dickson,Michael S. Gordon,Gerald M. Edelman,Johanna C. Bendell,Ragini R. Kudchadkar,Patricia LoRusso,Stuart H. Johnston,Douglas O. Clary,Gary K. Schwartz	23
3	Phase I evaluation of XL019, an oral, potent, and selective JAK2 inhibitor 2013 ·Leukemia Research ·Srđan Verstovšek,Constantine S. Tam,Martha Wadleigh,Lubomir Sokol,Catherine C. Smith,Lynne A. Bui,Chunyan Song,Douglas O. Clary,(unknown),Jörge E. Cortes,Hagop Kantarjian,Neil P. Shah	37
4	Preliminary Clinical Activity in a Phase I Trial of the BCR-ABL/IGF- 1R/Aurora Kinase Inhibitor XL228 in Patients with Ph++ Leukemias with Either Failure to Multiple TKI Therapies or with T315I Mutation 2008 ·Blood ·Jörge E. Cortes,Ronald Paquette,Moshe Talpaz,(unknown),Ekatherine Asatiani,Meir Wetzler,Jeffrey H. Lipton,Corynn Kasap,Lynne A. Bui,Douglas O. Clary,Neil P. Shah	43
5	Pharmacological Abrogation of S-Phase Checkpoint Enhances the Anti-Tumor Activity of Gemcitabine In Vivo 2007 ·Cell Cycle ·David J. Matthews,(unknown),Jason Chen,(unknown),Lester M. Bornheim,Douglas O. Clary,Albert Tai,Jill M. Wagner,Nicole Miller,(unknown),Scott Robertson,(unknown),Larry M. Karnitz	109
6	Anaplastic lymphoma kinase is dynamically expressed on subsets of motor neurons and in the peripheral nervous system 2006 ·The Journal of Comparative Neurology ·(unknown),Douglas O. Clary,Valérie Copié,Frances Lefcort	44
7	Transcriptional-Based Screens for Pathway-Specific, High-Throughput Target Discovery in Endothelial Cells 2004 ·SLAS DISCOVERY ·Robert L. Yauch,Edward E. Kadel,Cory R. Nicholas,(unknown),Douglas O. Clary	4
8	TrkA Activation Is Sufficient to Rescue Axotomized Cholinergic Neurons 1996 ·Neuron ·(unknown),Douglas O. Clary,Louis F. Reichardt,Fred H. Gage	44
9	trkA, CGRP and IB4 expression in retrogradely labelled cutaneous and visceral primary sensory neurones in the rat 1996 ·Neuroscience Letters ·David Bennett,(unknown),John V. Priestley,Douglas O. Clary,Stephen B. McMahon	145
10	Postnatal Changes in the Expression of the trkA High‐affinity NGF Receptor in Primary Sensory Neurons 1996 ·European Journal of Neuroscience ·(unknown),Sharon Averill,Douglas O. Clary,John V. Priestley,Stephen B. McMahon	145
11	TrkA‐immunoreactive profiles in the central nervous system: Colocalization with neurons containing p75 nerve growth factor receptor, choline acetyltransferase, and serotonin 1994 ·The Journal of Comparative Neurology ·Teresa Sobreviela,Douglas O. Clary,Louis F. Reichardt,Melanie Brandabur,Jeffrey H. Kordower,Elliott J. Mufson	293
12	NOS induction by NGF in basal forebrain cholinergic neurones: evidence for regulation of brain NOS by a neurotrophin 1994 ·Neurobiology of Disease ·David M. Holtzman,Joshua F. Kilbridge,David S. Bredt,Stephen M. Black,Yiwen Li,Douglas O. Clary,Louis F. Reichardt,William C. Mobley	49
13	SNAP family of NSF attachment proteins includes a brain-specific isoform 1993 ·Nature ·Sidney W. Whiteheart,(unknown),Michael Brunner,Douglas O. Clary,Thomas U. Mayer,S A Buhrow,James E. Rothman	241
14	[30] Purification of soluble N-ethylmaleimide-sensitive fusion attachment proteins from bovine brain microsomes 1992 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Douglas O. Clary,James E. Rothman	6
15	SNAPs, a family of NSF attachment proteins involved in intracellular membrane fusion in animals and yeastbreakdown → 1990 ·Cell ·Douglas O. Clary,(unknown),James E. Rothman	447
16	Drosophila mitochondrial DNA: Conserved sequences in the A+T-rich region and supporting evidence for a secondary structure model of the small ribosomal RNA 1987 ·Journal of Molecular Evolution ·Douglas O. Clary,David R. Wolstenholme	134
17	The mitochondrial DNA molecule ofDrosophila yakuba: Nucleotide sequence, gene organization, and genetic codebreakdown → 1985 ·Journal of Molecular Evolution ·Douglas O. Clary,David R. Wolstenholme	1361
18	The ribosomal RNA genes ofDrosophilamitochondrial DNA 1985 ·Nucleic Acids Research ·Douglas O. Clary,David R. Wolstenholme	125
19	SEQUENCE EVOLUTION OF DROSOPHILA MITOCHONDRIAL DNA 1985 ·Genetics ·David R. Wolstenholme,Douglas O. Clary	111
20	Sequence and arrangement of the genes for cytochromeb, URF1, URF4L, URF4, URF5, URF6 and five tRNAs inDrosophilamitochondrial DNA 1984 ·Nucleic Acids Research ·Douglas O. Clary,Jill A. Wahleithner,David R. Wolstenholme	51

About Douglas O. Clary

Douglas O. Clary is a scholar working on Genetics, Cellular and Molecular Neuroscience and Developmental Neuroscience, having authored 40 papers that have together received 4.6k indexed citations. Recurring topics across this work include RNA and protein synthesis mechanisms (9 papers), Nerve injury and regeneration (8 papers) and Mitochondrial Function and Pathology (6 papers). The work is most often cited by research in Developmental Neuroscience (340 citations), Cellular and Molecular Neuroscience (1.0k citations) and Insect Science (643 citations). Douglas O. Clary has collaborated with scholars based in United States, France and Italy. Frequent co-authors include David R. Wolstenholme, James E. Rothman, Louis F. Reichardt, Frances Lefcort, John V. Priestley, Stephen B. McMahon, Melanie Brandabur, Elliott J. Mufson, Teresa Sobreviela and Jeffrey H. Kordower. Their work appears in journals such as Nature, Cell and Nucleic Acids Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact